# Chuangyu Investment Management

> Chuangyu Investment Management is a VC fund in Huangpu backing Health Care and Biotechnology. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Huangpu, China
- Total investments: 5
- Last investment: May 2024
- Lead investor: 20%
- Last updated: Aug 2026
- Website: http://www.cyinvestment.com.cn/

Chuangyu Investment Management is an investment firm that provides asset management and investment management service.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 40% |
| Biotechnology | 2 | 40% |
| Manufacturing | 2 | 40% |
| Pharmaceutical | 2 | 40% |
| Medical | 1 | 20% |

10 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 2 | 40% |
| Series C | 2 | 40% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 3 | 60% |
| United States | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| ONYX BOOX | ONYX BOOX offers a truly paper-like experience for reading and note-taking. |  | Series B | May 07, 2024 |  |
| Bostal Drug Delivery | Bostal Drug Delivery develops and manufactures drug preparation products for new drug delivery systems. The company provides pharmaceutical preparation technology platforms to develop innovative drugs, improve new drugs, and high-end generic drugs. It also offers preparation products technical development services for pharmaceutical companies.Thecompany was founded in 2013 and is headquartered in Guangzhou, Guangdong. |  | Series B | Aug 18, 2023 |  |
| Regenex Corporation | Regenex Corporation is a pharmaceutical company that is involved in research and development, production, and sales of reproductive health medicines, chronic disease medicines, and external medicines. They implement GPS track management for marketing personnel and implement terminal standard methods for marketing. | $14M | Series C | Jun 16, 2023 |  |
| Bostal Drug Delivery | Bostal Drug Delivery develops and manufactures drug preparation products for new drug delivery systems. The company provides pharmaceutical preparation technology platforms to develop innovative drugs, improve new drugs, and high-end generic drugs. It also offers preparation products technical development services for pharmaceutical companies.Thecompany was founded in 2013 and is headquartered in Guangzhou, Guangdong. |  | Series B | Apr 19, 2022 |  |
| Raise3D | Raise3D is a professional designer and manufacturer of FFF 3D printer in the world, which consolidates talents from Fortune 500 and prestigious universities such as MIT, Fudan University, and focus on technology research and application of 3d printing. The company provides products and services to customers in the field of industrial design,manufacturing, medical service, culture creative, research institution, architecture, and cultural preservation. It is determined to develop 3D Printing technology with all its partners. Their version is to renovate traditional manufacturing and improve human life with 3D printing technology. Raise3D sets up offices in the USA, China, Hong Kong, Singapore, Australia, and Korea, with these offices they provide professional and great service to customers.The Santa Clara, California-based company was established in 2014. | $15.8M | Series C | Feb 18, 2022 |  |

5 of 5 investments shown.

## Co-investors
- [Blue Lake Capital](https://shizune.co/investors/profile/blue-lake-capital-ag) — VC Fund, 1 deal together
- [BOC & Utrust Private Equity Fund Management](https://shizune.co/investors/profile/boc-utrust-private-equity-fund-management) — VC Fund, 1 deal together
- [Fortune Venture Capital](https://shizune.co/investors/profile/fortune-venture-capital) — VC Fund, 1 deal together
- [GF Securities](https://shizune.co/investors/profile/gf-securities) — VC Fund, 1 deal together
- [Gimpo Fund](https://shizune.co/investors/profile/gimpo-fund) — VC Fund, 1 deal together
- [Guangdong Technology Financial Group](https://shizune.co/investors/profile/guangdong-technology-financial-group) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Chuangyu Investment Management invest in?

Chuangyu Investment Management invests primarily in Health Care, Biotechnology and Manufacturing startups, most often at Series B and Series C stage. Most of the 5 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Chuangyu Investment Management last invest?

The most recent investment recorded for Chuangyu Investment Management closed in May 2024. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co